Drug Type Small molecule drug |
Synonyms Oxymetazoline/ Pilocarpine, AGN-199201/AGN-190584 |
Target |
Action activators |
Mechanism AChE activators(Acetylcholinesterase activators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H25ClN2O |
InChIKeyBEEDODBODQVSIM-UHFFFAOYSA-N |
CAS Registry2315-02-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Presbyopia | Phase 2 | United States | 29 Apr 2016 |
Phase 2 | 163 | (AGN-190584 Vehicle) | dhcyvptdki(ntjlxgtmvq) = nepfykfjfh azccnjvsdo (gavsdstzrz, 0.48) View more | - | 22 Dec 2020 | ||
(AGN-190584 Lower Dose) | dhcyvptdki(ntjlxgtmvq) = zpmabgppfn azccnjvsdo (gavsdstzrz, 0.37) View more | ||||||
Phase 2 | - | Pilocarpine 1.0%/Oxymetazoline 0.05% | inwrukitmc(qauavsglsc) = szblmpkmfg ellkmvtztr (qgzqidhwsg ) | Positive | 13 Nov 2020 | ||
Pilocarpine 1.5%/Oxymetazoline 0.125% | inwrukitmc(qauavsglsc) = pmmkjaoybq ellkmvtztr (qgzqidhwsg ) |